BRAIN Biotech AG

Equities

BNN

DE0005203947

Environmental Services & Equipment

Market Closed - Xetra Other stock markets 11:36:18 2025-02-14 am EST			5-day change	1st Jan Change
2.750 ^EUR	-0.72%		-4.51%	-22.54%

Feb. 13	BRAIN Biotech AG Collaborates with PX Group on the PX Urban Mining Initiative	CI
Jan. 14	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	CI

La Cultura Verde Ltd. acquired LA Schmitt from BRAIN Biotech AG.

September 25, 2022

La Cultura Verde Ltd. acquired LA Schmitt from BRAIN Biotech AG (XTRA:BNN) on September 26, 2022. BRAIN Biotech will have additional cash reserves after the transaction to finance its ambitious growth targets in the areas of industry and science.

La Cultura Verde Ltd. completed the acquisition of LA Schmitt from BRAIN Biotech AG (XTRA:BNN) on September 26, 2022.

Latest news about BRAIN Biotech AG

BRAIN Biotech AG Collaborates with PX Group on the PX Urban Mining Initiative	Feb. 13	CI
BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	Jan. 14	CI
BRAIN Biotech AG - Analyst/Investor Day	Dec. 12
BRAIN Biotech AG Announces Resignation of Wiltrud Treffenfeldt as Member of the Supervisory Board	24-10-03	CI
Brain Biotech Signs EUR129 Million Royalty Deal for Hereditary Angioedema Treatment Compound	24-09-23	MT
BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	24-08-29	CI
BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	24-05-28	CI
Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	24-04-16	MT
BRAIN Biotech AG and AMSilk GmbH Announce the Successful Completion of the First Phase of A Development Collaboration	24-03-05	CI
BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2023	24-02-28	CI
BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2023	24-01-17	CI
BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-29	CI
BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-25	CI
BRAIN Biotech AG, Q2 2023 Earnings Call, May 25, 2023	23-05-25
BRAIN Biotech to Look Acquisitions	23-05-24	CI
BRAIN Biotech AG acquired remaining 17.8% stake in Biocatalysts Limited for ?9.6 million.	23-05-23	CI
SolasCure Limited announced that it has received £10.9 million in funding from Seneca Partners Limited, BRAIN Biotech AG, Eva Pharma Consultants Ltd, Wealth Club Limited and another investor	23-03-26	CI
BRAIN Biotech AG announced that it expects to receive ?5 million in funding from MP Beteiligungs-Gmbh	23-03-07	CI
BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-27	CI
BRAIN Biotech Ends Contract with Roquette Frères on Natural Sweetener Joint Development	23-02-10	MT
BRAIN Biotech Unit to Focus on Developing New Therapies Via Genome-editing Technology	23-01-10	MT
BRAIN Biotech AG Announces Executive Changes	23-01-08	CI
BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2022	22-11-28	CI
La Cultura Verde Ltd. acquired LA Schmitt from BRAIN Biotech AG.	22-09-25	CI
BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-28	CI

Chart BRAIN Biotech AG

Duration

Period

BNN: Dynamic Chart

Company Profile

BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.

Employees

318

Sector

Environmental Services & Equipment

Calendar

2025-02-26 - Q1 2025 Earnings Release

More about the company